Anger Can Harm The Health of Our Bodies
October 26, 2011 by admin
Filed under Mental Health
Anger is one of basic human nature and can not be eliminated from our body. In theory, anger or anger is a defense mechanism which relied on when the goals and expectations are not successful. Best efforts in overcoming anger is to control it, but if we let the anger will become worse.
Experts say there are some adverse effects caused by the uncontrolled anger. In addition, anger can harm the health of our bodies, among others as described below.
- Anger can cause heart and blood pressure rise
When we lose control of our bodies will receive their impact directly. increased blood pressure and breathing rhythm became faster. In this condition of high blood pressure that can cause sudden headache. If this happens in a long time can increase the risk of heart attack. - Anger can lead to fatigue
when we are angry we seemed to hold Kendal. But in reality it will reduce our energy until the end. These conditions will make our body tired. - Anger causes insomnia
When we are angry we certainly can not sleep well. Lack of sleep will lead to negative thoughts that can trigger emotions. Ultimately this condition causes the body to be insomnia. - Anger can lead to depression
Save the anger for a long time can cause depression. Sometimes people use anger to express depression and weakness. This of course can be harmful to health.
That’s four important points that I can describe in this article. We should be able to control our anger so that we can live well and healthy. And I hope this article is useful for the readers.
anger as defense mechanism, when anger causes insomnia,Benefits of Revlimid for Against Chronic Leukemia
September 14, 2011 by admin
Filed under Mental Health
The drug Revlimid (lenalidomide) may be effective for some people with chronic lymphocytic leukemia (CLL) that has not responded to other treatments or comes back after treatment, according to a small Phase 2 study. If the results hold true in larger clinical trials, Revlimid may prove to be another option for patients who otherwise have few treatments left to try.
Why it’s important: CLL is considered an incurable form of cancer. Although many people live for many years with this disease, it does eventually come back after treatment. There are not many treatments that work in this situation, especially if people have already been treated with the chemotherapy drug fludarabine. Patients need more effective ways to tackle CLL after their initial treatments.
What’s already known: Revlimid was approved in 2005 to treat a type of bone marrow disorder called myelodysplastic syndrome. It has also shown promise against multiple myeloma, another type of bone marrow cancer. In lab studies, the drug appears to decrease the production of substances that help CLL cells survive, and to encourage the leukemia cells to die through a natural process called apoptosis. Those studies prompted the researchers, from the Roswell Park Cancer Institute in Buffalo, New York, to try Revlimid in patients with CLL. They published their findings in the Journal of Clinical Oncology.
How this study was done: The study included 45 people who had not responded to their CLL treatment or who had had a relapse after successful treatment. Most had been diagnosed with stage III or IV leukemia and were therefore considered high-risk patients. Participants took a Revlimid pill once a day. Treatment continued until the patients showed a response or had unacceptable side effects. Patients whose cancer progressed during treatment were given the drug Rituxan (rituximab) in addition to Revlimid.
What was found: Of the patients in whom a response could be measured, four (9%) had a complete response (no evidence of remaining disease) and 17 (38%) had a partial response to the Revlimid treatment. One patient died, and 3 saw their disease progress.
The Revlimid caused some side effects, including fatigue, low platelet counts, and low white cell counts. Two patients developed serious blood clots in the lungs. More than half of the participants in the study also experienced a flare reaction, which is a sudden swelling of the lymph nodes or spleen accompanied by fever and rash. This side effect was treated with ibuprofen. Patients who enrolled in the study later were given prednisone to make the flare reaction less severe if it did develop.
The bottom line: Although the researchers are concerned by the high percentage of side effects with the dose used in this study, they say Revlimid warrants further study in people with CLL. Future studies should explore different doses of Revlimid, and try combining Revlimid with other drugs that are effective against CLL (like Rituxan and the chemotherapy drug fludarabine), they say.
revlimid, revlimid cll chronic lymphocytic leukemia, revlimid and rituximab side effects, revlimid cll 2011, revlimid side effects,Why Heart Disease Can Make Deadly For Women
February 26, 2011 by admin
Filed under Mental Health
A woman who has heart disease is 50% more likely to die from it than a man who has it. Although experts can point to a number of possible explanations for this, the research on women and heart disease remains inadequate, says the new edition of a Harvard Medical School report, The Healthy Heart: Preventing, detecting, and treating coronary artery disease.
Even though men are more likely to develop cardiovascular disease than women, about 38% of women who have a heart attack die within a year of the event, compared with 25% of men. And women are almost twice as likely as men to have a second heart attack within six years of the first.
The science behind the differences is unclear.
These are some of the theories discussed in The Healthy Heart:
Age. Women seem to become more vulnerable to heart disease only after their estrogen levels fall with menopause, and so they tend to suffer first heart attacks later than men. Advanced age may make it more difficult to survive a heart attack.
Coronary microvascular disease. This new diagnosis may apply to 50% to 60% of women, compared with 20% of men. These people have chest pain when they are active or stressed, but on angiograms, their coronary arteries appear clear. Studies show that women with coronary microvascular disease have a higher risk for heart attack or stroke.
Inferior diagnosis and treatment. Some studies suggest women’s heart problems don’t receive the same attention as men’s.
Incomplete understanding of symptoms. Classic heart attack symptoms were defined based on studies on men. These symptoms don’t always occur in women, which may delay diagnosis and treatment.